Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Development of Method of Fructose Identification in Urine to Detect the Viral Infection

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by Kaohsiung Medical University Chung-Ho Memorial Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier:
NCT01638312
First received: January 20, 2012
Last updated: September 28, 2012
Last verified: September 2012

January 20, 2012
September 28, 2012
June 2011
May 2013   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01638312 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Development of Method of Fructose Identification in Urine to Detect the Viral Infection
The Development of Fast and Simple Method of Fructose Identification in Urine to Detect the Viral Infection in Early Stage

The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage. There will be 30 samples from the HIV-infected patients and 30 samples from the heath controls. The study will collect 10ml urine and examined fructose and fructose-diphosphate using the polarographic method.

The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage.

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   None Retained
Description:

urine

Non-Probability Sample

the person who has HIV infection

Human Immunodeficiency Virus
Not Provided
HIV infection patient
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
May 2013
May 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • HIV infection

Exclusion Criteria:

  • who are in HARRT therapy
Both
Not Provided
Yes
Contact: JihJin Tsai, MD 886-7-3121101 ext 5677 jijits@cc.kmu.edu.tw
Taiwan
 
NCT01638312
KMUH-IRB-20110188
Yes
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Not Provided
Principal Investigator: JihJin Tsai, MD The Medicines Company
Kaohsiung Medical University Chung-Ho Memorial Hospital
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP